Pharmaceutical product development: A quality by design approach.

Area of Science:

• Pharmaceutical Science
• Regulatory Science
• Drug Development

Background:

• Quality by Design (QbD) is a key focus for regulatory bodies and the pharmaceutical industry.
• International Conference on Harmonization and USFDA guidance highlight QbD principles in pharmaceutical development.
• QbD is integrated into regulatory reviews, such as the USFDA's question-based review for abbreviated new drug applications.

Purpose of the Study:

• To review the principles and applications of Quality by Design (QbD) in pharmaceutical product development.
• To highlight the importance of QbD in fostering a science-based approach.
• To discuss key QbD elements and their role in ensuring product performance.

Main Methods:

• Review of QbD principles and their implementation in pharmaceutical development.
• Discussion of key QbD elements: target product quality profile, critical quality attributes, risk assessments, design space, control strategy, and lifecycle management.
• Exploration of tools like Design of Experiments, risk assessment, and Process Analytical Technology in QbD.

Main Results:

• QbD implementation leads to successful product development and prompt regulatory approval.
• Adoption of QbD principles significantly reduces validation burden and post-approval changes.
• QbD facilitates understanding of dosage form performance within the defined design space.

Conclusions:

• Quality by Design (QbD) is crucial for a science-based approach in pharmaceutical product development.
• Effective implementation of QbD elements ensures product quality and regulatory compliance.
• QbD supports continuous improvement and efficient lifecycle management of pharmaceutical products.